Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
This study is conducted in Japan. The aim of this study is to collect information about the
 efficacy and safety of Norditropin® (somatropin) in the long-term treatment of short stature
 with GHD (Growth Hormone Deficiency) where epiphysial discs are not closed and short stature
 with Turner Syndrome where epiphysial discs are not closed.
Inclusion Criteria:

 -  Growth hormone deficiency or short stature due to Turner Syndrome where the epiphyseal
 discs are not closed

 Exclusion Criteria:

 -  Diabetic

 -  Patients with malignant tumors

 -  Women who are either pregnant or likely to be pregnant

 -  Known or suspected allergy to study product(s) or related products